Medical Condition News

RSS

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.

10 Jul 2013

Lifestyle modification programs may reduce risk of heart attack in people with coronary heart disease

Lifestyle modification programs that addressed at least two health behaviors lowered the risk of a fatal heart attack or stroke in people with coronary heart disease, finds a new systematic review in the American Journal of Preventive Medicine.

10 Jul 2013

Study shows rates of brain loss caused by aging and AD are higher for women

The rates of regional brain loss and cognitive decline caused by aging and the early stages of Alzheimer's disease (AD) are higher for women and for people with a key genetic risk factor for AD, say researchers at the University of California, San Diego School of Medicine in a study published online July 4 in the American Journal of Neuroradiology.

10 Jul 2013

Researchers show cerebrovascular disease affecting blood circulation in brain associated with dementia

Researchers in the Perelman School of Medicine at the University of Pennsylvania found that, across a variety of neurodegenerative diseases, cerebrovascular disease affecting circulation of blood in the brain was significantly associated with dementia.

10 Jul 2013

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.

10 Jul 2013

Research: Boosting levels of gut hormones may be effective weapon in fight against obesity

In the constant cross talk between our brain and our gut, two gut hormones are already known to tell the brain when we have had enough to eat. New research suggests that boosting levels of these hormones simultaneously may be an effective new weapon in the fight against obesity.

10 Jul 2013

Study shows female obesity may reduce receptivity of uterus to embryo implantation

An analysis of almost 10,000 first cycles of egg donation treatment at one of Europe's largest IVF centres shows that female obesity reduces the receptivity of the uterus to embryo implantation and thereby compromises reproductive outcome.

10 Jul 2013

Study highlights importance of doctors asking parents, children about asthma symptoms

The allergist's office might not be a child's favorite place to visit, but it is a place where they should be able to say how their asthma makes them feel. While children might rely on parents to tell their doctor about how they are feeling, according to a study released today, children should do most of the talking.

10 Jul 2013

Precautionary methods for parents to protect their children from sun exposure

Marty Visscher, Ph.D., Director, Skin Sciences Program at Cincinnati Children's Hospital Medical Center, explains that some parents do not understand the dangers of prolonged sun exposure on their child's skin.

10 Jul 2013

Study shows disrupted micronuclei may prove to be a valuable tool for detecting cancer

Scientists studying cancer development have known about micronuclei for some time. These erratic, small extra nuclei, which contain fragments or whole chromosomes that were not incorporated into daughter cells after cell division, are associated with specific forms of cancer and are predictive of poorer prognosis.

10 Jul 2013

Age-old practice of annual screening exams for cervical cancer may be harmful than helpful

For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new recommendation that women be screened less frequently: every three years rather than annually.

10 Jul 2013

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Low vitamin D blood levels are linked to greater risk of heart disease in whites and Chinese, but not in blacks and Hispanics, according to a study appearing this week in JAMA, a journal published by the American Medical Association.

10 Jul 2013

Solid food for infants before 4 months may have greater risk of Type 1 diabetes

Infants who get their first solid food before 4 months of age and after 6 months may have a higher risk of developing Type 1 diabetes, University of Colorado researchers have found.

10 Jul 2013

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

The New Jersey Commission on Spinal Cord Injury Research awarded three grants to scientists at Kessler Foundation. The grants, which exceed $1.2 million, fund studies of assisted walking with Ekso, the impact of aging in the population with spinal cord injury (SCI) and the effects of electrical stimulation on bone loss.

10 Jul 2013

Researcher uncover biomarkers from stem cells derived from bone marrow of ALS patients

Amyotrophic Lateral Sclerosis (ALS) is a devastating motor neuron disease that rapidly atrophies the muscles, leading to complete paralysis. Despite its high profile - established when it afflicted the New York Yankees' Lou Gehrig - ALS remains a disease that scientists are unable to predict, prevent, or cure.

10 Jul 2013

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.

9 Jul 2013

FORMA Therapeutics, CRT partner to discover therapeutic drug candidates against DUBs

FORMA Therapeutics and Cancer Research Technology, Ltd., the commercialization company of Cancer Research UK, announced today a bold research initiative to discover innovative tools, technologies and therapeutic drug candidates against a variety of protein homeostasis regulators called, deubiquitinating enzymes.

9 Jul 2013

UIC to manage largest-ever prospective health study of Hispanic/Latino population

The University of Illinois at Chicago Institute for Minority Health Research will manage a National Institutes of Health project to follow up, over the next six years, all Chicago participants in the Hispanic Community Health Study/Study of Latinos—the largest-ever prospective health study of this population.

9 Jul 2013

Omthera submits Epanova NDA to FDA for treatment of severe hypertriglyceridemia

Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Epanova™ for the treatment for patients with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500mg/dL).

9 Jul 2013

NeuRA study: Orbitofrontal cortex plays key role in linking emotion, memories in FTD patients

A study by researchers at Neuroscience Research Australia (NeuRA) is the first to demonstrate that patients with frontotemporal dementia (FTD) lose the emotional content/colour of their memories. These findings explain why FTD patients may not vividly remember an emotionally charged event like a wedding or funeral.

9 Jul 2013

Medical Condition News

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Lifestyle modification programs may reduce risk of heart attack in people with coronary heart disease

Study shows rates of brain loss caused by aging and AD are higher for women

Researchers show cerebrovascular disease affecting blood circulation in brain associated with dementia

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

Research: Boosting levels of gut hormones may be effective weapon in fight against obesity

Study shows female obesity may reduce receptivity of uterus to embryo implantation

Study highlights importance of doctors asking parents, children about asthma symptoms

Precautionary methods for parents to protect their children from sun exposure

Study shows disrupted micronuclei may prove to be a valuable tool for detecting cancer

Age-old practice of annual screening exams for cervical cancer may be harmful than helpful

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Solid food for infants before 4 months may have greater risk of Type 1 diabetes

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

Researcher uncover biomarkers from stem cells derived from bone marrow of ALS patients

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

FORMA Therapeutics, CRT partner to discover therapeutic drug candidates against DUBs

UIC to manage largest-ever prospective health study of Hispanic/Latino population

Omthera submits Epanova NDA to FDA for treatment of severe hypertriglyceridemia

NeuRA study: Orbitofrontal cortex plays key role in linking emotion, memories in FTD patients

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News